Listed

Adma Biologics, Inc.

ADMANasdaqCIK 1368514HealthcareFiscal year ends Dec 31

Reports and events: 394 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Adma Biologics, Inc., Reports and events
FiledFormWhat it isAccession number
2024-02-2816:21 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-24-010100
2024-02-2816:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-24-010088
2024-02-2108:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-24-008680
2024-01-0808:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-24-001198
2024-01-0807:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-24-001194
2023-12-1816:30 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-058160
2023-12-1216:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-057341
2023-11-1616:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-053665
2023-11-0817:00 ET10-QQuarterly reportPeriod 2023-09-300001140361-23-052109
2023-11-0816:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-23-052102
2023-10-0216:45 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-23-046335
2023-08-0917:05 ET10-QQuarterly reportPeriod 2023-06-300001140361-23-038843
2023-08-0916:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-23-038803
2023-07-1907:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-035123
2023-06-0616:30 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001140361-23-028551
2023-05-2207:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-025873
2023-05-1017:00 ET10-QQuarterly reportPeriod 2023-03-310001140361-23-023920
2023-05-1016:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-23-023899
2023-05-0209:07 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-022312
2023-04-1316:31 ETDEF 14AProxy statementPeriod 2023-06-060001140361-23-018237
2023-03-2317:16 ET10-KAnnual reportPeriod 2022-12-310001140361-23-013467
2023-03-2316:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-23-013402
2023-03-1016:50 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-23-011200
2023-02-0807:22 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-005120
2023-01-1708:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-23-001727
2022-12-0917:00 ETSC 13D/AOwnership report, active investor, amended0000902664-22-005090
2022-12-0916:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-045106
2022-12-0709:01 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-044667
2022-12-0616:19 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-044592
2022-11-0917:16 ET10-QQuarterly reportPeriod 2022-09-300001140361-22-040738
2022-11-0916:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-22-040700
2022-10-3116:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-039119
2022-08-1017:26 ET10-QQuarterly reportPeriod 2022-06-300001140361-22-029116
2022-08-1016:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-22-029079
2022-06-2716:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-024139
2022-06-2117:00 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001140361-22-023666
2022-06-1316:30 ET8-K8.01 Other events0001140361-22-022769
2022-05-1116:45 ET10-QQuarterly reportPeriod 2022-03-310001140361-22-018668
2022-05-1116:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-22-018655
2022-04-2816:36 ETDEF 14AProxy statementPeriod 2022-06-210001140361-22-016578
2022-03-2516:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-011213
2022-03-2417:16 ET10-KAnnual reportPeriod 2021-12-310001140361-22-011030
2022-03-2417:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-22-011028
2022-03-0917:17 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-22-008654
2022-03-0716:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-008174
2022-02-0408:30 ETSC 13DOwnership report, active investor0000902664-22-001112
2022-01-1908:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-22-001914
2022-01-1808:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-001782
2021-12-2116:48 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-21-042611
2021-12-0908:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-21-040956

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:34 ET. Listed shows no prices and gives no investment advice.